| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |